Effects of cannabis use on age at onset in schizophrenia and bipolar disorder (Q34128935)

31 July 2017

title

Effects of cannabis use on age at onset in schizophrenia and bipolar disorder (English)

1 reference

31 July 2017

0 references

1 reference

1 reference

8

Joseph Peuskens

1 reference

31 July 2017

1

Marc De Hert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20674280

14 June 2024

4

Tomislav Franic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20674280

14 June 2024

author name string

Martien Wampers

2

1 reference

31 July 2017

Tihana Jendricko

3

1 reference

31 July 2017

Domagoj Vidovic

5

1 reference

31 July 2017

Nele De Vriendt

6

1 reference

31 July 2017

Kim Sweers

7

1 reference

31 July 2017

Ruud van Winkel

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

full work available at URL

31 July 2017

https://api.elsevier.com/content/article/PII:S0920996410014180?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

https://api.elsevier.com/content/article/PII:S0920996410014180?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

14 June 2024

published in

Schizophrenia Research

1 reference

31 July 2017

volume

126

1 reference

31 July 2017

issue

1-3

1 reference

31 July 2017

page(s)

270-276

1 reference

Co-occurring disorders among mentally ill jail detainees: Implications for public policy

31 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Impact of an early psychosis program on substance use.

14 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Twin study of illness history variables in psychosis.

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Comorbid substance use and age at onset of schizophrenia

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Age at onset in bipolar I affective disorder: further evidence for three subgroups

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cocaine abuse among schizophrenic patients

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Family history of psychiatric disorders and age at first contact in schizophrenia: an epidemiological study.

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis and schizophrenia: results of a follow-up study

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Risk factors for homelessness among schizophrenic men: a case-control study

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

HIV seroprevalence among people with severe mental illness in the United States: a critical review

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

The significance of age of onset for schizophrenia

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Complications of severe mental illness related to alcohol and drug use disorders.

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Alcohol use and abuse in schizophrenia. A prospective community study

14 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis and psychosis/schizophrenia: human studies

14 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Comorbidity of bipolar disorder and substance abuse in Costa Rica: pedigree- and population-based studies

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

14 June 2024

Cannabis and psychosis

27

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Patterns of current and lifetime substance use in schizophrenia

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

A history of substance abuse complicates remission from acute mania in bipolar disorder

14 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Impact of cannabis and other drugs on age at onset of psychosis.

14 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Recent victimization in women and men with severe mental illness: prevalence and correlates

14 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Schizophrenia and comorbid substance use disorder: effects of antipsychotics

14 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Treatment of schizophrenia and comorbid substance use disorder

14 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

14 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis use and misuse prevalence among people with psychosis

14 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Relapse in schizophrenia: is there a relationship to substance abuse?

14 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Substance abuse and the onset of schizophrenia

14 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective

14 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

The environment and schizophrenia: the role of cannabis use.

14 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis use and expression of mania in the general population

14 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition

14 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life

14 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Criminal victimization of persons with severe mental illness

14 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF).

14 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample.

14 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Psychosis risk as a function of age at onset: a comparison between early- and late-onset psychosis in a general population sample

14 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis

14 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Early detection and intervention in first-episode schizophrenia: a critical review

14 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study

14 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis abuse and the course of recent-onset schizophrenic disorders

14 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis use and cognition in schizophrenia

14 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis and psychotic illness

14 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?

14 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults

14 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

14 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

From real-world events to psychosis: the emerging neuropharmacology of delusions

14 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk

14 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Comorbidity of schizophrenia and substance abuse: implications for treatment

14 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups

14 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey

14 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Duration of untreated psychosis: a critical examination of the concept and its importance

14 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Clinical characteristics influencing age at onset in psychotic disorders

14 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Medication noncompliance and substance abuse among patients with schizophrenia

14 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses

14 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis

14 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

14 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.

14 June 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

A population based elaboration of the role of age of onset on the course of schizophrenia

14 June 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

14 June 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Recent psychostimulant use in hospitalized schizophrenics

14 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness

14 June 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

The role of cannabis in cognitive functioning of patients with schizophrenia

14 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder

14 June 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

14 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Substance abuse and bipolar affective disorder.

14 June 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

The effects of antecedent substance abuse on the development of first-episode psychotic mania

14 June 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Twelve-Month Outcome After a First Hospitalization for Affective Psychosis

14 June 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization.

14 June 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

The impact of substance abuse on the course of bipolar disorder

14 June 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis use and age of diagnosis of schizophrenia

14 June 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Violence and psychiatric disorder in the community: evidence from the Epidemiologic Catchment Area surveys

14 June 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Screening for serious mental illness in populations with co-occurring substance use disorders: Performance of the K6 scale

14 June 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.

14 June 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis and psychosis. Is there epidemiological evidence for an association?

14 June 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis

14 June 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Does Cannabis Use Affect Treatment Outcome in Bipolar Disorder?

14 June 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder.

14 June 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

Cannabis use and age at onset of schizophrenia

14 June 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.SCHRES.2010.07.003

14 June 2024

Identifiers

1 reference

release_3pojsa47kfekpm752n6644nwx4

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3pojsa47kfekpm752n6644nwx4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference